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CASE REPORT
Eosinophilic pleural effusion (EPE), first de-
scribed by Harmsen in 1894, is defined as pleural
effusion that contains at least 10% eosinophils
among the leukocytes, and can be a manifestation
of a great variety of diseases. However, eosinophilia
is a relatively rare finding in malignant pleural
effusions. Adelman et al concluded that the pres-
ence of pleural fluid eosinophilia reduces the
probability of malignancy and denotes a benign
underlying disorder.1 That view has been chal-
lenged by three other studies.2–4 In clinical expe-
rience, however, very few cases of malignant
lymphomas accompanied by EPE have been 
reported.5–8 Here, we report an unusual case of 
angioimmunoblastic T cell lymphoma (AITL)
presenting initially with EPE.
Case Report
An 82-year-old man, a non-smoker, visited our
chest outpatient department with the complaint
of progressive dyspnea of 5 days’ duration. The
dyspnea was associated with fever, dry cough, and
poor appetite. The patient was a farmer and denied
any history of asthma or chronic obstructive 
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pulmonary disease; he had not taken any drug be-
fore this event. Chest radiography showed left
massive pleural effusion and he was admitted for
further evaluation.
On physical examination, his temperature was
38.1°C, pulse rate was 102/minute, respiratory
rate was 22/minute, and blood pressure was 178/
84 mmHg. The neck was supple and no lym-
phadenopathy was found. Chest examination re-
vealed diminished breath sounds on the left side.
No hepatosplenomegaly was noted. Hematologic
study showed: red blood cell count, 4.32 × 106/μL;
hemoglobin, 10.7 g/dL; white blood cell count,
9910/μL; neutrophils, 65.8%; lymphocytes, 14.2%;
eosinophils, 12%; platelets, 277,000/μL. Serum
biochemistries were all within normal limits ex-
cept albumin (2.6 g/dL) and globulin (3.7 g/dL).
Chest radiography revealed left large pleural
effusion (Figure 1). Diagnostic thoracentesis
yielded an exudative pleural effusion (total pro-
tein, 3.9 g/dL; lactate dehydrogenase, 288 IU/L)
with eosinophilia (white blood cell count, 890/μL;
neutrophils, 27%; lymphocytes, 53%; eosinophils,
17%; monocytes, 3%). Cytologic examinations of
pleural effusion and sputum were negative for
malignancy. Chest computed tomography did not
reveal additional information, and there was no
pericardial fluid seen on the examination.
Pathologic examination of the pleural biopsy
specimen revealed patchy lymphocytic collections
and dense eosinophilic infiltrate (Figure 2), but
a definite diagnosis could not be made initially.
As the symptoms were relieved by thoracentesis,
the patient refused further examination and he
was discharged. Subsequently, he experienced
dyspnea 3 weeks later and bilateral pleural effu-
sion developed. He was readmitted; pleural fluid
was re-examined and showed exudative effusion
with eosinophilia (21%), a similar result as that
obtained previously. However, hookworm ova were
found in the stool. Parasite associated with EPE
was suspected and mebendazole was prescribed.
After a complete treatment course, stool examina-
tion was negative for hookworm ova. However,
pleural effusion continued to progress. Fiberoptic
bronchoscopy with bronchoalveolar lavage showed
negative findings, including for parasite.
After admission, he was followed-up regularly
in our outpatient clinic and frequent thoracenteses
for symptom relief were needed. Six months
later, bilateral neck, axillary and inguinal lym-
phadenopathy developed. Pathologic examination
of the lymph node specimen allowed a definite
diagnosis to be made of AITL with positive CD10
expression (Figure 3). Therefore, we retrospectively
Figure 1. Chest radiography on admission shows left mas-
sive pleural effusion.
Figure 2. Pleural biopsy revealed patchy lymphocytic col-
lections and dense eosinophilic infiltrate (hematoxylin &
eosin, 200×).
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carried out CD10 staining of the sample obtained
from the pleural biopsy (Figure 4) and the positive
result confirmed that the etiology of the EPE was
due to malignant lymphoma. As the patient re-
fused chemotherapy, supportive care was the
principal treatment and he died 1 month after
diagnosis.
Discussion
EPE accounts for 5–16% of exudative pleural ef-
fusion.1–4 Most information about EPE comes
from small series and case reports.9 A considerable
proportion of these patients (343 cases of EPE
reported in the English literature up to 1983) have
A
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Figure 3. Biopsy of right inguinal lymph node. (A) Architec-
tural effacement by polymorphous lymphoid infiltrates mainly
composed of medium to large lymphoid cells containing
abundant clear cytoplasm (hematoxylin & eosin, 400×). 
(B) These atypical lymphoid cells show dense immunoreac-
tivity with CD3, indicating the T cell phenotype. (C) Scattered
immunoreactivity with CD10 represents aberrant pheno-
typic expression of the atypical T lymphocytes (DAB as chro-
mogen, counterstained with hematoxylin, 400×).
BA
Figure 4. Retrospective immunohistochemistry of pleural biopsy. (A) Extensive CD3 staining, indicating a predominant 
T cell phenotype. (B) Dense immunoreactivity with CD10 represents aberrant phenotypic expression of T lymphocytes
(DAB as chromogen, counterstained with hematoxylin, 400×).
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been summarized previously by Adelman et al.1
Since then, most of the information has come
from four studies.2–4,10 EPE occurs most com-
monly during conditions associated with the pres-
ence of blood or air in the pleural space, infections
and malignancy. Drug-induced pleural effusion,
pleural effusion accompanying pulmonary em-
bolism, and benign asbestos pleural effusion are
also common causes of EPE. Air/blood was the
most common cause of EPE in the studies re-
viewed by Adelman et al (29%)1 and Spriggs and
Boddington (64%).11
Parasites are also etiologies of EPE. Among
parasites that cause EPE, the most frequent is
Paragonimus spp.,9 which is endemic in Eastern
and Southeastern Asia. Other parasitic diseases
associated with EPE are sparganosis, toxocariasis,
cutaneous myiasis, loiasis, strongyloidiasis, echi-
nococcosis, lymphatic filariasis, ascariasis, and
amebiasis.9 In this patient, hookworm ova was
found in the stool. Although hookworm-associated
EPE has not been previously reported, that was
the rational first impression because no evidence
of other EPE-causing etiology could be found at
the time.
AITL is a rare subtype of lymphoma, making
up only 1–2% of non-Hodgkin lymphomas.12
Patients with AITL are mostly elderly. Although
generalized lymphadenopathy is the main present-
ing sign, many patients have evidence of extranodal
involvement at the time of diagnosis.13 The most
frequently involved extranodal sites include the
bone marrow, spleen, skin and lungs. Among the
commonly reported presenting symptoms and
signs, ascites/effusion account for 23–37%.13 In
our patient, pleural involvement was the first
presenting sign and no lymphadenopathy could
be found at that time. Histologic appearance in
extranodal sites is usually nonspecific and cytologic
features of malignancy can rarely be identified.13
This explained why the initial pleural biopsy and
cytology could not yield a definite diagnosis in
this patient.
The relationship between EPE and malignancy
is controversial. The frequency of malignancy in
EPE varied between 6% and 40% in different
studies.1–4,9,10,14,15 The prevalence of EPE in ma-
lignant pleural effusion varied between 2.3% and
11.6%.1–4,16–18 Adelman et al concluded that the
presence of pleural fluid eosinophilia decreased
the likelihood that a pleural effusion is malig-
nant.1 However, that view was challenged by the
three more recent studies2–4 that included 1058
patients in total (111 with EPE). According to those
three studies, malignancy was as prevalent among
EPE as among non-EPE. Overall, 27% of the 
patients with EPE and 29.8% of those with no
EPE had malignant pleural effusion.
Pleural effusion is a relatively common finding
in patients with non-Hodgkin lymphoma, with a
frequency of up to 20%.19 However, very few cases
of malignant lymphomas accompanied by EPE
have been reported.5–8 In these reports, malignant
cells were not detected in the pleural effusion, but
spotted lesions were found on the pleural surface
at autopsy in one report.5 In our case, malignant
cells were not detected in the pleural effusion and
pleural biopsy could not yield a definitive diag-
nosis initially. But retrospective CD10 staining of
the sample obtained from pleural biopsy proved
the malignant cell invasion. The treatment of AITL
consists of combination chemotherapy.14 Although
a complete remission rate of 50% can be achieved,
relapse rates remain high. The prognosis for AITL
patients is poor, with a median survival <3 years.12
In conclusion, we found that EPE may not 
always indicate a benign disease. It could be an
initial sign that develops up to several months
before the full presentation of malignant T cell
lymphoma.
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